îæ€çŽ¢
îæ€çŽ¢
î
Enliven Therapeutics Inc
ELVNîãŠã©ãããªã¹ãã«è¿œå
48.943USD
-1.807-3.56%
ååŒæé ïŒETïŒ15åé
ãã®æ ªäŸ¡
2.98Bæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
åçäºæž¬
é貚: USD æŽæ°æå»:ã¢ããªã¹ãè©äŸ¡
12
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
62.100
ç®æšæ ªäŸ¡
+22.12%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
561
åèš
5
äžå€®å€
6
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
Enliven Therapeutics Inc
ELVN
12
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
ãããã質å
Enliven Therapeutics Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãEnliven Therapeutics Inc ã®ç®æšæ ªäŸ¡ã USD 38.00 ãšäºæ³ããæé«äºæ³ã¯ USD 52.00ãæäœäºæ³ã¯ USD 33.00 ãšäºæ³ããŠããŸãã
Enliven Therapeutics IncELVN ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -0.38 ã§ããããEnliven Therapeutics IncELVN ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.48 ã§ããã次ã®ååæã® EPS 㯠USD -0.41 ãšäºæ³ãããŸãã
Enliven Therapeutics Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î12 ã¢ããªã¹ãã«ãã Enliven Therapeutics Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« Enliven Therapeutics Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã